Description
This compendium of essential drug data helps when planning clinical research projects and choosing drugs with specific properties. As well as covering established drugs, data is presented on compounds about to be marketed or in the last stages of clinical development. Anaesthetics and neuromuscular blockers; analgesic and anti-migraine blockers; analgesic and anti-migraine agents; anti-gout and related agents; anthelminthic agents; anti-arrhythmic agents; anti-coagulant, anti-platelet and lipid-lowering agents; anti-depressant agents; anti-diabetic agents; anti-epilectic agents; anti-fungal agents; anti-hypertensive agents; anti-nausea and anti-vertigo agents; anti-neoplastic and immunosuppressant agents; anti-inflammatory agents; anti-Parkinson and related agents; anti-protozoal agents; anti-psychotic agents; anti-spasmodic, anti-ulcer and anti-diarrheoa agents; anti-tuberculous and anti-leprotic agents; barbiturates and related agents; beta-adrenoceptor antagonists; calcium antagonists and peripheral vasodilators; cardiovascular agents; cephalosporins and other anti-infective agents; cerebral vasodilators and sympathomimetics; corticosteroids; hormones and their antagonists; monoamino-oxidase inhibitors and appetite suppressants; miscellaneous agents; penicillins; quinolone antibiotics; repiratory agents; sulphonamides and other anti-bacterials; tetracyclines, aminoglycosides and related agents; thyroid and anti-thyroid agents.
